Cena s DPH / bez DPH
Hlavní stránka>BS EN ISO 5840-3:2021 Cardiovascular implants. Cardiac valve prostheses Heart valve substitutes implanted by transcatheter techniques
sklademVydáno: 2021-02-08
BS EN ISO 5840-3:2021 Cardiovascular implants. Cardiac valve prostheses Heart valve substitutes implanted by transcatheter techniques

BS EN ISO 5840-3:2021

Cardiovascular implants. Cardiac valve prostheses Heart valve substitutes implanted by transcatheter techniques

Formát
Dostupnost
Cena a měna
Anglicky Zabezpečené PDF
K okamžitému stažení
8700 Kč
Čtěte normu po dobu 1 hodiny. Více informací v kategorii E-READING
Čtení normy
na 1 hodinu
870.00 Kč
Čtěte normu po dobu 24 hodin. Více informací v kategorii E-READING
Čtení normy
na 24 hodin
2610.00 Kč
Anglicky Tisk
Skladem
8700 Kč
Označení normy:BS EN ISO 5840-3:2021
Počet stran:66
Vydáno:2021-02-08
ISBN:978 0 539 02794 5
Status:Standard
Popis

BS EN ISO 5840-3:2021


This standard BS EN ISO 5840-3:2021 Cardiovascular implants. Cardiac valve prostheses is classified in these ICS categories:
  • 11.040.40 Implants for surgery, prosthetics and orthotics

This document is applicable to all devices intended for implantation as a transcatheter heart valve substitute.

This document is applicable to transcatheter heart valve substitutes and to the accessory devices, packaging and labelling required for their implantation and for determining the appropriate size of heart valve substitute to be implanted.

This document establishes an approach for verifying/validating the design and manufacture of a transcatheter heart valve substitute through risk management. The selection of appropriate verification/validation tests and methods are to be derived from the risk assessment. The tests can include those to assess the physical, chemical, biological and mechanical properties of heart valve substitutes and of their materials and components. The tests can also include those for preclinical in vivo evaluation and clinical evaluation of the finished heart valve substitute.

This document defines operational conditions and performance requirements for transcatheter heart valve substitutes where adequate scientific and/or clinical evidence exists for their justification.

This document includes considerations for implantation of a transcatheter heart valve substitute inside a pre-existing prosthetic device (e.g. valve-in-valve and valve-in-ring configurations).